15 results
Diabetic Peripheral Neuropathy - Pharmacotherapy

Peripheral neuropathy is a common microvascular complication of diabetes. In clinic patients
Diabetic Peripheral ... complication of diabetes ... clinic patients should ... pregabalin as treatment ... #Pharmacology #
Comparison of anti-diabetic or anti-hyperglycemic agents

There are numerous anti-hyperglycemic agents available to manage Type 2 diabetes.
Comparison of anti-diabetic ... manage Type 2 diabetes ... risks, and therapy should ... #pharmacology #pharmacotherapy ... endocrinology #treatment
Management of Diabetes Mellitus in Patients With CKD

1. Monitor for changes in BP, serum creatinine, &
Management of Diabetes ... initiation of treatment ... recommends, metformin should ... and CKD should ... evidence-based pharmacologic
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
IDSA Recommendations ... HIV aged 21–29 should ... • Pap test should ... #Prevention #Treatment ... infections #HIVAIDS #pharmacology
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
IDSA - Clinical ... Individualized Treatment ... isolate DST result should ... antimicrobials #regimens #pharmacology ... #dosing #idsa #
Veltassa (Patiromer) 
MECHANISM: Potassium Binder 
INDICATION: Treatment of Hyperkalemia 
FORMULATION: Powder for oral suspension 
DOSING: 8.4
INDICATION: Treatment ... with CKD, HF, or diabetes ... conditions, RAAS meds ... #Hyperkalemia #Pharmacology
IDSA Diabetic Foot infection - In Which Situations Is Diagnostic Bone Biopsy Most Recommended?
 • Patient
IDSA Diabetic Foot ... favor of prolonged treatment ... directed therapy (should ... metalware #IDSA ... #Diabetic #Foot
IDSA Recommendations for Treating Cytomegalovirus Infections in HIV-AIDS
Preventing CMV Disease:
 • CMV end-organ disease is best
IDSA Recommendations ... CMV retinitis should ... should include ... Cytomegalovirus #CMV #IDSA ... infections #HIVAIDS #pharmacology
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist
Dosing:
3 mg daily x 30 days, then 7 mg
Patients should ... patients to take meds ... #semaglutide #Diabetes ... #Pharmacology #
IDSA - Approach to Treating a Patient With Diabetic Foot Osteomyelitis
When to consider a trial of
IDSA - Approach ... a Patient With Diabetic ... of nonsurgical treatment ... 48–72 h if on treatment ... explanation • Inability